STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry)

Size: px
Start display at page:

Download "STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry)"

Transcription

1 STEMCYTE INDIA s impeccable transplant record (Unmatched in Cord Blood industry) 1 1

2 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml 1 Patient 1 RELAPSED BILINEAGE LEUKEMIA HLA match TNC count (10*7) APOLLO- CHENNAI 75 5/ Patient 2 AML G.C.R.I-AHMEDABAD 75 5/ Patient 3 THAL. MAJOR RUBY HALL -PUNE 75 5/ Patient 4 THAL. MAJOR G.C.R.I-AHMEDABAD 75 4/ Patient 5 THAL. MAJOR G.C.R.I-AHMEDABAD 75 3/ CD 34+ (10*5) 6 Patient 6 Thalassemia Major Shayadri Deenanath Mangeshkar (Pune) 75 5/ Patient 7 Thalassemia Major APOLLO AHMEDABAD 75 6/ Patient 8 APLASTIC ANEMIA RUBY HALL-PUNE 75 4/ Patient 9 SCID APOLLO-CHENNAI 75 6/ Patient 10 Hurler's Syndrome APOLLO- CHENNAI 75 5/

3 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml HLA match TNC count (10*7) CD 34+ (10*5) 11 Patient 11 Thalassemia Major GCRI Ahmedabad 75 5/ Patient 12 THAL. MAJOR CHANG GUNG HOSPITAL- TAIWAN 75 5/ Patient 13 SCID APOLLO - CHENNAI 75 5/ Patient 14 FACONI ANEMIA APOLLO CHENNAI 75 5/ Patient 15 Relapsed Acute Lymphoblastic leukaemia (ALL) APOLLO CHENNAI 75 4/ Patient 16 Thalassemia Major 17 Patient 17 Aplastic Anemia STERLING HOSP- AHMEDABAD Shayadri Deenanath Mangeshkar (Pune) 78 4/ / Patient 18 Thalassemia Major Shayadri Deenanath Mangeshkar (Pune) 75 5/ Patient 19 Thalassemia Major Apollo Ahmedabad 75 6/ Patient 20 Thalassemia Major Apollo Speciality Hospital, Chennai 75 5/

4 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml HLA match 21 Patient Patient 22 Thalassemia Major Chronic Granulomatous Deenanath Mangeshkar Hospital, Pune Deenanath Mangeshkar Hospital, Pune 75 5/ / Patient 23 HLH AIIMS, Delhi 75 5/ Patient Patient Patient 26 Thalassemia Major Thalassemia Major Thalassemia Major Apollo Hospital, Chennai Gangaram Hospital, Delhi B.L Kapoor Hospital, India 75 6/ / / Patient 27 ALL AIIMS, Delhi 75 5/ Patient 28 ALL AIIMS, Delhi 79 4/ Patient 29 Thalassemia Major 30 Patient 30 AML Apollo Chennai 27 5/ Apollo Hospital, Hyderabad TNC count (10*7) CD 34+ (10*5) 75 5/ /

5 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml HLA match TNC count (10*7) CD 34+ (10*5) 31 Patient 31 ALL AIIMS, Delhi 104 4/ Patient 32 HLH Apollo Specialty Hospital, Chennai 75 5/ Patient 33 ALL AIIMS, Delhi 75 5/ Patient 34 Thalassemia Apollo Gleneagles Hospitals, Kolkata 85 4/ Patient 35 AML AIIMS, Delhi 79 5/ Patient 36 Relapsed Leukamia Safe Blood Organisation, New Delhi 78 5/ Patient 37 MDS AIIMS, Delhi 133 4/ Patient 38 CGD Sahyadri Superspeciality - Pune 75 5/ Patient 39 SCID AIIMS, Delhi 75 5/ Patient 40 AML AIIMS, Delhi 75 5/

6 No. Patient Name Diseases Transplant Centers Cord Blood Volume in ml HLA match TNC count (10*7) CD 34+ (10*5) 41 Patient 41 ALL AIIMS, Delhi 75 4/ Patient 42 LAD AIIMS, Delhi 75 5/ Patient 43 CEP AIIMS, Delhi 75 5/ Patient 44 MPS AIIMS, Delhi 75 5/ Patient 45 Griselli Syndrome AIIMS, Delhi 128 5/ Patient 46 Thalassemia Apollo Chennai 39 5/ Patient 47 WAS AIIMS, Delhi / Disease abbreviations AML: Acute Myeloid leukemia SCID: Severe Combined immunodeficiency ALL: Acute Lymphoblastic leukemia CGD: Chronic Granulomatous Disease HLH: Hemophagocytic Lymphohistiocytosis MDS: Myelodysplastic Syndrome MPS: mucopolysaccharidoses LAD: Leukocyte Adhesion molecule disease WAS: Wiskott Aldrich Syndrome CEP: Congenital Erythropoietic Porphyria 6

7 TNC/Volume STEMCYTE INDIA s impeccable transplant record Highest Volume and TNC counts Recorded Volume of the Unit TNC Count (10*7) Figure 1 : The graph demonstrates a direct relationship between volume collected and TNC preserved. As highlighted in the graph higher the volume higher the TNC. Due to our patented Plasma Depletion(PD) technology, STEMCYTE has proven to deliver highly efficient Cord Blood Units Patients Figure 1 : The graph demonstrates a direct relationship between Cord Blood volume stored and TNC preserved. As highlighted in the graph higher the volume higher the TNC. STEMCYTE INDIA has proven to deliver higher efficient Cord Blood Units hence best engraftment due to our patented Plasma Depletion(PD) technology, 7

8 9 % 6/6 70 % 5/6 ~98% HLA Match 19 % 2 % 4/6 3/6 Figure 2 : The above graph demonstrates 98% of STEMCYTE INDIA'S Cord Blood Transplants (CBT) were successfully done with 4/6,5/6 and 6/6 HLA matched Cord Blood Units. 8

9 MPS (Mucopolysaccharidosis) LAD (Leukocyte Adhesion defeciency) Acute lymphocytic leukemia (ALL) Infantile ALL Leukemia HLH Relapsed ALL CGD Fanconi Anemia Hurler's Syndrome Griscelli Syndrome with HLH MDS SCID Aplastic anemia CEP (Congenital Erythropoietic Porphyria) Relapsed Bilineage Leukemia Acute Myeloid Lymphoma (AML) Thalassemia Major Diseases Treated Relapsed Bilineage Leukemia Acute Myeloid Lymphoma (AML) Thalassemia Major Aplastic anemia Figure 3 : Cord Blood has been efficiently used for majorly all Hematological diseases i.e. ~80 diseases and STEMCYTE has the distinction of treating most of the diseases successfully including rare diseases as shown in the above pie chart. Disease abbreviations AML: Acute Myeloid leukemia SCID: Severe Combined immunodeficiency ALL: Acute Lymphoblastic leukemia CGD: Chronic Granulomatous Disease HLH: Hemophagocytic Lymphohistiocytosis MDS: Myelodysplastic Syndrome MPS: mucopolysaccharidoses LAD: Leukocyte Adhesion molecule disease WAS: Wiskott Aldrich Syndrome CEP: Congenital Erythropoietic Porphyria 9 SCID Hurler's Syndrome Fanconi Anemia Relapsed ALL CGD HLH Infantile ALL Acute lymphocytic leukemia (ALL) Leukemia MDS LAD (Leukocyte Adhesion defeciency) MPS (Mucopolysaccharidosis)

10 Figure 4 : A spectrum of rare diseases are successfully treated with ~100% engraftment. STEMCYTE INDIA quality redefined 10

11 11

A GLOBAL REGENERATIVE THERAPEUTICS COMPANY. A Commitment to EXCELLENCE. IMPECCABLE TRANSPLANT RECORD Unmatched in cord blood industry

A GLOBAL REGENERATIVE THERAPEUTICS COMPANY. A Commitment to EXCELLENCE. IMPECCABLE TRANSPLANT RECORD Unmatched in cord blood industry A GLOBAL REGENERATIVE THERAPEUTICS COMPANY A Commitment to EXCELLENCE IMPECCABLE TRANSPLANT RECORD Unmatched in cord blood industry IT HAPPENS ONLY IN STEMCYTE A GLOBAL REGENERATIVE THERAPEUTICS COMPANY

More information

Standard Therapies - Cord Blood

Standard Therapies - Cord Blood A healthy future is in your hands 01 02 03 04 Standard Therapies - Cord Blood Clinical Trials with Blood - Forming Stem Cells Gene Therapy for Inherited Disorders Using Blood - Forming Stem Cells Clinical

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

Applications of Cord Blood Stem Cells

Applications of Cord Blood Stem Cells Applications of Cord Blood Stem Cells over 360 families have used their banked cord blood in transplant or regenerative medicine research. 1 88 ViaCord has released over 360 units for transplant or infusion

More information

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral

More information

Family Medical History Questionnaire (FMHQ)

Family Medical History Questionnaire (FMHQ) First, Last Name DOB: Cord Blood Bank Use Only: Family Medical History Questionnaire (FMHQ) NMDP CBU ID: Local CBU ID: NMDP Maternal ID: Today's Date: Local Maternal ID: Baby's Mother's Initials: Please

More information

InPOG Newsletter. May-Aug 2017 Vol 3, Issue 2. InPOG Executive. Subcommittee Chairs

InPOG Newsletter. May-Aug 2017 Vol 3, Issue 2. InPOG Executive. Subcommittee Chairs InPOG Newsletter May-Aug 2017 Vol 3, Issue 2 InPOG Executive Sameer Bakhshi Amita Trehan Deepak Bansal Tulika Seth Venkat Radhakrishnan Ramandeep Singh Arora Subcommittee Chairs ALL V Saha AML S Bakhshi

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Allogeneic Hematopoietic Transplant for Genetic Diseases and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: allogeneic_hematopoietic_transplant_for_genetic_diseases

More information

InPOG Newsletter. May-Aug 2016 Vol 2, Issue 3. InPOG Executive. Subcommittee Chairs. Dear InPOG members

InPOG Newsletter. May-Aug 2016 Vol 2, Issue 3. InPOG Executive. Subcommittee Chairs. Dear InPOG members InPOG Newsletter May-Aug 2016 Vol 2, Issue 3 InPOG Executive Sameer Bakhshi Amita Trehan Brijesh Arora Nitin Shah Deepak Bansal Tulika Seth V Radhakrishnan Ramandeep Singh Arora Subcommittee Chairs ALL

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT DEPARTMENT OF BONE MARROW TRANSPLANT About Narayana Health City Headquartered in Bangalore, Narayana Health has a network of hospitals across India witha

More information

InPOG Newsletter. Jan-Apr 2018, Vol 4, Issue 1. InPOG Executive. Subcommittee Chairs. Dear Friends,

InPOG Newsletter. Jan-Apr 2018, Vol 4, Issue 1. InPOG Executive. Subcommittee Chairs. Dear Friends, InPOG Newsletter Jan-Apr 2018, Vol 4, Issue 1 InPOG Executive Sripad Banavali (Chair) Revathy Raj (Co-Chair) Ramandeep Arora (Sec) Amita Mahajan Girish Chinnaswamy Nita Radhakrishnan Subcommittee Chairs

More information

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE

More information

INFORMATION KIT H PE. IS IN YOUR NEWBORN S BLOOD Help it last a lifetime with cord blood banking. Save $300 with Promo Code.

INFORMATION KIT H PE. IS IN YOUR NEWBORN S BLOOD Help it last a lifetime with cord blood banking. Save $300 with Promo Code. INFORMATION KIT H PE IS IN YOUR NEWBORN S BLOOD Help it last a lifetime with cord blood banking Save $300 with Promo Code Cord4Life CORD BLOOD STEM CELLS Umbilical cord blood is unique and is only available

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT DEPARTMENT OF BONE MARROW TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service

More information

BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016

BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016 BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016 David Rice, PhD, RN, NP Director, Professional Practice

More information

Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT

Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT Stem cells -Dr Dinesh Bhurani, MD, DM, FRCPA -Director, Department of Haematology and BMT Rajiv Gandhi Cancer Institute, Delhi, Flow of presentation Update on stem cell uses Haematopoietic stem cell transplantation

More information

Donating your baby s cord to a public cord blood bank can save lives globally.

Donating your baby s cord to a public cord blood bank can save lives globally. Donating your baby s cord to a public cord blood bank can save lives globally. You can play an important role in saving lives by donating the blood contained in your baby s umbilical cord to LifeCord,

More information

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS ACQUIRED ANEMIAS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are

More information

babycell.in SMS Babycell to 56677

babycell.in SMS Babycell to 56677 1800-209-0309 babycell.in SMS Babycell to 56677 R R One life. One opportunity. Congratulations on your pregnancy! Your little miracle will soon make your world more beautiful and happier. As expecting

More information

anemias: the current situation

anemias: the current situation Bone Marrow transplantation in rare anemias: the current situation Dr. Daria Pagliara, MD Pediatric Onco Haematology Department Ospedale Pediatrico Bambino Gesù, Rome 4th European Symposium on Rare Anaemias

More information

No Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)

No Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs) Units Used In Transplants/Infusions No Other Company Discloses Higher Transplant Survival Rate Family Banking Provides Exclusive Access To Emerging Treatments With Your Own Cells 175 85% Type 1 Diabetes

More information

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Policy Number: Original Effective Date: MM.07.001 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO

More information

Hematopoetic Stem Cell Therapies in TURKIYE

Hematopoetic Stem Cell Therapies in TURKIYE Hematopoetic Stem Cell Therapies in TURKIYE World Location of transplant centers participating in CIBMTR (2010) Dr. Mustafa ÇETİN Mustafa CETIN, M.D. Erciyes University Medical Faculty Kayseri-TURKIYE

More information

Hematopoietic Stem Cell Therapy

Hematopoietic Stem Cell Therapy Hematopoietic Stem Cell Therapy Grace Totoe, MBChB, SBB CME August 2012 Accra-Ghana Hematopoietic Stem Cells Cells capable of self renewal and differentiation into all blood cell lineages Objectives Historical

More information

Haploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia

Haploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia Haploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia Carmem Bonfim Director Pediatric Blood and Marrow Transplantation Program HC Federal

More information

MP Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

MP Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Medical Policy MP 8.01.22 BCBSA ef. Policy: 8.01.22 Last eview: 01/30/2018 Effective Date: 01/30/2018 Section: Therapy elated Policies 8.01.25 Hematopoietic Cell Transplantation for Autoimmune Diseases

More information

Preface In recent years, the pathogenesis of hematological disorders in children has been clarified, which has led to remarkable progress in the treatment outcome for these disorders. In particular, molecular

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): October 1, 2014 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

Pediatric Hematopoietic Stem Cell Transplant - Experience of an Indian Tertiary Care Center

Pediatric Hematopoietic Stem Cell Transplant - Experience of an Indian Tertiary Care Center Pediatric Hematopoietic Stem Cell Transplant - Experience of an Indian Tertiary Care Center Dr Chirag A Shah Diplomate American Board of Hematology and Medical Oncology Director, Dept of Hemato-Oncology

More information

Pediatric Hematology-Oncology

Pediatric Hematology-Oncology Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS

More information

DEPARTMENT OF CLINICAL HEMATOLOGY

DEPARTMENT OF CLINICAL HEMATOLOGY DEPARTMENT OF CLINICAL HEMATOLOGY What is blood? Blood is the vital fluid of the body, which performs diverse functions from delivering oxygen to each and every cell of the body to fighting against infections

More information

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children VOLUME 46 ㆍ NUMBER ㆍ March 0 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children Meerim Park, Kyung

More information

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Medical Policy Manual Transplant, Policy No. 45.25 Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias Next eview: January 2019 Last eview: February 2018 Effective:

More information

BMTCN Review Course Basic Concepts and Indications for Transplantation. David Rice, PhD, RN, NP

BMTCN Review Course Basic Concepts and Indications for Transplantation. David Rice, PhD, RN, NP BMTCN Review Course Basic Concepts and Indications for Transplantation March 16, 2017 David Rice, PhD, RN, NP Director, Professional Practice and Education No disclosures Objectives Describe basic concepts

More information

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. Robert Liwski, MD, PhD, FRCPC Medical Director HLA Typing Laboratory Department of Pathology Dalhousie

More information

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam: Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist

More information

Distribution of Leukemia in Chennai Population:- An Epidemiological Study

Distribution of Leukemia in Chennai Population:- An Epidemiological Study Research Article Distribution of Leukemia in Chennai Population:- An Epidemiological Study Devika Warrier E*, MP Brundha Department of General Pathology, Saveetha University, 162, P.H Road, Chennai, Tamil

More information

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias Policy Number: 8.01.22 Last Review: 7/2014 Origination: 7/2002 Next Review: 7/2015 Policy Blue Cross and Blue

More information

Stem Cell Transplantation for Severe Aplastic Anemia

Stem Cell Transplantation for Severe Aplastic Anemia Number of Transplants 10/24/2011 Stem Cell Transplantation for Severe Aplastic Anemia Claudio Anasetti, MD Professor of Oncology and Medicine Chair, Blood and Marrow Transplant Dpt Moffitt Cancer Center

More information

Give Birth to Hope: An Unique Approach to Public Cord Blood Donation

Give Birth to Hope: An Unique Approach to Public Cord Blood Donation Give Birth to Hope: An Unique Approach to Public Cord Blood Donation The Public Health Nursing and Professional Development Unit, North Carolina Division of Public Health, is approved as a provider of

More information

Haematopoietic stem cell transplantation (SCT)

Haematopoietic stem cell transplantation (SCT) HAEMATOPOIETIC TEM CELL TRANPLANTATION FOR CHILREN IN BELGIUM Marie-Françoise resse 1 & Yves Beguin 2 1 epartment of Paediatrics, ivision of Hemato-Oncology, UHOPL, University of Liege, Liège, Belgium;

More information

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American

More information

Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update

Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update Dr Chirag A Shah Diplomate American Board of Hematology and Medical Oncology Director, Dept of Hemato-Oncology and Stem Cell Transplant

More information

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias. Original Policy Date

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias. Original Policy Date MP 7.03.15 Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date

More information

Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation?

Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation? HEMATOPOIETIC STEM CELL TRANSPLANTATION I: EXPLOITING ALTERNATIVE DONORS Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation? Andrea

More information

Stem Cells And The Future of Regenerative Medicine. Dipnarine Maharaj, M. D., FACP

Stem Cells And The Future of Regenerative Medicine. Dipnarine Maharaj, M. D., FACP Stem Cells And The Future of Regenerative Medicine Dipnarine Maharaj, M. D., FACP The following potential conflict of interest relationships are germane to my presentation. Employment: South Florida Bone

More information

ASPHO 2019 Review Course January 31-February 2, 2019

ASPHO 2019 Review Course January 31-February 2, 2019 ASPHO 2019 Review Course January 31-February 2, 2019 ABP Content Outline Topics by Date and Speaker For additional information, see the ABP Content Outline and the ABP Content Outline with Speaker Assignments.

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

THE ROLE OF TBI IN STEM CELL TRANSPLANTATION. Dr. Biju George Professor Department of Haematology CMC Vellore

THE ROLE OF TBI IN STEM CELL TRANSPLANTATION. Dr. Biju George Professor Department of Haematology CMC Vellore THE ROLE OF TBI IN STEM CELL TRANSPLANTATION Dr. Biju George Professor Department of Haematology CMC Vellore Introduction Radiotherapy is the medical use of ionising radiation. TBI or Total Body Irradiation

More information

Blood & Marrow Transplantation Center

Blood & Marrow Transplantation Center Blood & Marrow Transplantation Center We were one of the first centers in the world to routinely offer patients blood and marrow transplantation (BMT). What Sets Us Apart High-volume center performs about

More information

Immunodeficiency. By Dr. Gouse Mohiddin Shaik

Immunodeficiency. By Dr. Gouse Mohiddin Shaik Immunodeficiency By Dr. Gouse Mohiddin Shaik Immunodeficieny Immunodeficiency is failure of immune system to protect against disease or malignency Immunodeficiency is of two types Primary Secondary immunodeficiency

More information

4000: Cellular Therapy Essential Data Pre-Infusion Form

4000: Cellular Therapy Essential Data Pre-Infusion Form 4000: Cellular Therapy Essential Data Pre-Infusion Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: / / CIBMTR Form 4000 revision 3 (page 1 of 19). Last

More information

Table of Contents. 1.0 Description of the Procedure, Product, or Service... 1

Table of Contents. 1.0 Description of the Procedure, Product, or Service... 1 Allogeneic Hematopoietic & Bone Clinical Coverage Policy No: 11A-5 Marrow Transplant for Genetic Amended Date: October 1, 2015 Diseases and Acquired Anemias Table of Contents 1.0 Description of the Procedure,

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)

More information

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand This list provides indications for the majority of adult BMTs that are performed in New Zealand. A small number of BMTs

More information

Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait])

Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait]) Immunodeficiency and Skin (September 21, 2018) By (Arti Nanda, MD, DNBE [Kuwait]) Immune deficiency refers to a state in which part of immune system is missing or defective resulting into an inability

More information

Evaluation of Early Post-transplant Leukocyte Recovery Using the Undiluted Erythrocyte Lysing Technique

Evaluation of Early Post-transplant Leukocyte Recovery Using the Undiluted Erythrocyte Lysing Technique Annals of Clinical & Laboratory Science, vol. 32, no. 2, 2002 159 Evaluation of Early Post-transplant Leukocyte Recovery Using the Undiluted Erythrocyte Lysing Technique Myungshin Kim, 1 Ja Young Kim,

More information

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist? Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Colony Stimulating Factors (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

Pediatric Hematopoietic Stem Cell Transplantation. Meng Yao Lu/ Kai Hsin Lin Department of Pediatrics National Taiwan University Hospital

Pediatric Hematopoietic Stem Cell Transplantation. Meng Yao Lu/ Kai Hsin Lin Department of Pediatrics National Taiwan University Hospital Pediatric Hematopoietic Stem Cell Transplantation Meng Yao Lu/ Kai Hsin Lin Department of Pediatrics National Taiwan University Hospital Outline Overview Indication Stem cell source New revolution Cord

More information

Sub-Class Code Sub-Classification Other code. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired. Pure red cell aplasia (non

Sub-Class Code Sub-Classification Other code. Bone Marrow failures including 7 Aplastic Anaemia 77 Other 1 Acquired. Pure red cell aplasia (non ification Sub- Sub-ification code Absence of T & B cells SCID 8 Inherited Disorders 1 Primary immune deficiencies Absence of T, normal B cell SCID 8 Inherited Disorders 1 Primary immune deficiencies Acquired

More information

SEAT MATRIX - FELLOWSHIP PROGRAMMES - CENTRALIZED COUNSELING ADMISSION SESSION. Andhra Pradesh. Andhra Pradesh. Andhra Pradesh.

SEAT MATRIX - FELLOWSHIP PROGRAMMES - CENTRALIZED COUNSELING ADMISSION SESSION. Andhra Pradesh. Andhra Pradesh. Andhra Pradesh. 1 3 4 5 6 7 Care Apollo Yashoda Super Fernandez Pvt. Ltd. Global s Ltd., Apollo, Road No. 1, Banjara Hills, Hyderabad - 34 Jubilee Hills, Hyderabad-34 Raj Bhavan Road, Somajiguda, Hyderabad-8 4-1-130,

More information

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should

More information

The Role of Outcomes Registries in Blood and Marrow Transplantation Mary M Horowitz, MD, MS Cape Town, South Africa November 2014

The Role of Outcomes Registries in Blood and Marrow Transplantation Mary M Horowitz, MD, MS Cape Town, South Africa November 2014 The Role of Outcomes Registries in Blood and Marrow Transplantation Mary M Horowitz, MD, MS Cape Town, South Africa November 2014 Worldwide Network for Blood and Marrow Transplantation Transplants A Little

More information

. TCR Alpha, Beta and CD19+ Cell Depleted Haploidentical Transplant for Primary Immunodeficiency Disorders Feb 22 nd,2018

. TCR Alpha, Beta and CD19+ Cell Depleted Haploidentical Transplant for Primary Immunodeficiency Disorders Feb 22 nd,2018 . TCR Alpha, Beta and CD19+ Cell Depleted Haploidentical Transplant for Primary Immunodeficiency Disorders Feb 22 nd,2018 Neena Kapoor Professor of Pediatrics Children s Hospital Los Angeles Keck School

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our

More information

Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012

Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012 MEDICAL POLICY Policy #: 190 Original policy date: 6/1/2010 Page: 1 of 9 Revised date: 5/1/2012 Title Allogeneic Hematopoietic Stem Cell Transplantation for Genetic Diseases and Acquired Description Hematopoietic

More information

Bone marrow is a specialized type of soft connective tissue called myeloid tissue. It serves as the site for production of

Bone marrow is a specialized type of soft connective tissue called myeloid tissue. It serves as the site for production of ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com BONE MARROW TRANSPLANTATION Powar P. V*, Ms.Tiwari.D.J, Dr. Sharma P. H Department of Pharmaceutics, Padmashree

More information

AGENDA CIBMTR WORKING COMMITTEE FOR METABOLIC AND IMMUNE DEFICIENCY DISORDERS Salt Lake City, Utah Wednesday, February 13, 2013, 12:15 2:15 pm

AGENDA CIBMTR WORKING COMMITTEE FOR METABOLIC AND IMMUNE DEFICIENCY DISORDERS Salt Lake City, Utah Wednesday, February 13, 2013, 12:15 2:15 pm Not for publication or presentation AGENDA CIBMTR WORKING COMMITTEE FOR METABOLIC AND IMMUNE DEFICIENCY DISORDERS Salt Lake City, Utah Wednesday, February 13, 2013, 12:15 2:15 pm Co-Chair: Co-Chair: Co-Chair:

More information

HAEMATOPOIETIC STEM CELL TRANSPLANTATION

HAEMATOPOIETIC STEM CELL TRANSPLANTATION PRIMARY IMMUNODEFICIENCIES HAEMATOPOIETIC STEM CELL TRANSPLANTATION HAEMATOPOIETIC STEM CELL TRANSPLANTATION 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS CID GvHD HSCT IPOPI PID SCID BMT HSC Combined

More information

What s a Transplant? What s not?

What s a Transplant? What s not? What s a Transplant? What s not? How to report the difference? Daniel Weisdorf MD University of Minnesota Anti-cancer effects of BMT or PBSCT [HSCT] Kill the cancer Save the patient Restore immunocompetence

More information

Clinical Policy Title: Bone marrow transplants

Clinical Policy Title: Bone marrow transplants Clinical Policy Title: Bone marrow transplants Clinical Policy Number: 14.02.06 Effective Date: January 1, 2016 Initial Review Date: November 18, 2015 Most Recent Review Date: November 16, 2016 Next Review

More information

SECOND ANNUAL INTERNATIONAL UMBILICAL CORD BLOOD SYMPOSIUM

SECOND ANNUAL INTERNATIONAL UMBILICAL CORD BLOOD SYMPOSIUM Biology of Blood and Marrow Transplantation 10:728-739 (2004) 2004 American Society for Blood and Marrow Transplantation 1083-8791/04/1010-0009$30.00/0 doi:10.1016/j.bbmt.2004.06.010 SECOND ANNUAL INTERNATIONAL

More information

Clinical Policy Title: Bone marrow transplants for cancer (other than breast cancer)

Clinical Policy Title: Bone marrow transplants for cancer (other than breast cancer) Clinical Policy Title: Bone marrow transplants for cancer (other than breast cancer) Clinical Policy Number: 14.02.06 Effective Date: January 1, 2016 Initial Review Date: November 18, 2015 Most Recent

More information

Acute Lymphoblastic and Myeloid Leukemia

Acute Lymphoblastic and Myeloid Leukemia Acute Lymphoblastic and Myeloid Leukemia Pre- and Post-Disease Form Acute Lympoblastic Leukemia Mary Eapen MD, MS Acute Lymphoblastic Leukemia SEER Age-adjusted incidence rate 1.6 per 100,000 men and women

More information

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER Regence Medicare Advantage Policy Manual Policy ID: M-TRA45 Stem Cell / Bone Marrow Transplants Published: 10/01/2018 Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT

More information

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018 Saudi Fellowship Training Program Final Written Examination of Adult Hematology 2018 Objectives: Determine the quantity and quality of a hematologist s knowledge base ranked as competent, so that the individual

More information

THIRD ANNUAL INTERNATIONAL UMBILICAL CORD BLOOD TRANSPLANTATION SYMPOSIUM

THIRD ANNUAL INTERNATIONAL UMBILICAL CORD BLOOD TRANSPLANTATION SYMPOSIUM Biology of Blood and Marrow Transplantation 11:921-927 (2005) 2005 American Society for Blood and Marrow Transplantation 1083-8791/05/1111-0009$30.00/0 doi:10.1016/j.bbmt.2005.08.028 THIRD ANNUAL INTERNATIONAL

More information

HEMATOLOGIC MALIGNANCIES BIOLOGY

HEMATOLOGIC MALIGNANCIES BIOLOGY HEMATOLOGIC MALIGNANCIES BIOLOGY Failure of terminal differentiation Failure of differentiated cells to undergo apoptosis Failure to control growth Neoplastic stem cell FAILURE OF TERMINAL DIFFERENTIATION

More information

Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting

Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting December 4, 2018 Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting - Key highlights include near universal engraftment

More information

Bin them or bank them?

Bin them or bank them? Bin them or bank them? What are stem cells? Single cells that can Differentiate into any one of 220 different specialised cells in the body or......replicate themselves Stem cells are often called master

More information

PGD: FROM DIAGNOSIS TO THERAPY

PGD: FROM DIAGNOSIS TO THERAPY PGD: FROM DIAGNOSIS TO THERAPY MC Magli, L. Gianaroli Reproductive Medicine Unit - Via Mazzini, 2-438 Bologna www.sismer.it Since the birth of the first baby conceived using IVF techniques in 978 over

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423

More information

Introduction to Hematopoietic Stem Cell Transplantation

Introduction to Hematopoietic Stem Cell Transplantation Faculty Disclosures Introduction to Hematopoietic Stem Cell Transplantation Nothing to disclose Jeanne McCarthy-Kaiser, PharmD, BCOP Clinical Pharmacist, Autologous Stem Cell Transplant/Long- Term Follow-Up

More information

CLIC Sargent Eligibility Criteria

CLIC Sargent Eligibility Criteria 1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd

More information

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish

More information

Clinical Policy: Donor Lymphocyte Infusion

Clinical Policy: Donor Lymphocyte Infusion Clinical Policy: Reference Number: PA.CP.MP.101 Effective Date: 01/18 Last Review Date: 11/16 Coding Implications Revision Log This policy describes the medical necessity requirements for a donor lymphocyte

More information

Clinical Use of Umbilical Cord Blood Hematopoietic Stem Cells

Clinical Use of Umbilical Cord Blood Hematopoietic Stem Cells Biology of Blood and Marrow Transplantation 12:34-41 (2006) 2006 American Society for Blood and Marrow Transplantation 1083-8791/06/1201-0107$32.00/0 doi:10.1016/j.bbmt.2005.09.006 Clinical Use of Umbilical

More information

Granix. Granix (tbo-filgrastim) Description

Granix. Granix (tbo-filgrastim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.16 Subject: Granix 1 of 7 Last Review Date: December 2, 2016 Granix Description Granix (tbo-filgrastim)

More information

NEWS FROM. Roswell Park s BLOOD AND MARROW TRANSPLANT PROGRAM

NEWS FROM. Roswell Park s BLOOD AND MARROW TRANSPLANT PROGRAM NEWS FROM Roswell Park s BLOOD AND MARROW TRANSPLANT PROGRAM THE BLOOD AND MARROW TRANSPLANT TEAM Philip McCarthy, MD Medical Director, BMT Program Hong Liu, MD, PhD Attending Physician Our multidisciplinary

More information

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019 SAUDI FELLOWSHIP TRAINING PROGRAM Adult Haematology Final Written Examination 2019 Examination Format: A. The Saudi fellowship specialty final written examination shall consist of one paper with 80-120

More information

HEMATOPOIETIC STEM CELL TRANSPLANT

HEMATOPOIETIC STEM CELL TRANSPLANT HEMATOPOIETIC STEM CELL TRANSPLANT Protocol: TRP011 Effective Date: February 1, 2018 Table of Contents Page RELATIVE CONTRAINDICATIONS... 1 GENERAL INFORMATION... 3 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY...

More information

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017 Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis

More information

Medical Policy. MP Placental and Umbilical Cord Blood as a Source of Stem Cells

Medical Policy. MP Placental and Umbilical Cord Blood as a Source of Stem Cells Medical Policy MP 7.01.50 BCBSA Ref. Policy: 7.01.50 Last Review: 01/30/2018 Effective Date: 01/30/2018 Section: Surgery Related Policies 8.01.20 Hematopoietic Cell Transplantation for Non- Hodgkin Lymphomas

More information

Childhood Leukemia Causes, Risk Factors, and Prevention

Childhood Leukemia Causes, Risk Factors, and Prevention Childhood Leukemia Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for childhood

More information

CordLife Secures US Department of Defense Contract

CordLife Secures US Department of Defense Contract THEGUARDIAN Year 2004 - Eighth Issue. Mita (P) 119/11/2002 A Newsletter from CordLife CordLife Secures US Department of Defense Contract CordLife announced that its Boston-based subsidiary, Cytomatrix

More information

Aplastic anamia & Sideroblastic anemia

Aplastic anamia & Sideroblastic anemia Hematology Lecture 7 كلية التقنيات الصحية والطبية قسم التحليالت المرضية Aplastic anamia & Sideroblastic anemia اإلعداد: ظفر جبار دهاق فؤاد APLASTIC ANEMIA What is Aplastic anemia? Aplastic anemia is a

More information

PREDICAGEN LLC REPORT

PREDICAGEN LLC REPORT The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because

More information